FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,706 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 49200 - 49400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2998.jsonNonimmune Hydrops (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2999.jsonNumbness (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3000.jsonNumbness (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3001.jsonOptic Neuropathy (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3002.jsonOptic Neuropathy (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3003.jsonOsteitis (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3004.jsonOsteitis (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3005.jsonParalysis (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3006.jsonParalysis (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3007.jsonUveitis (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3008.jsonUveitis (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3009.jsonVertigo (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3010.jsonVertigo (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3011.jsonTenosynovitis [Unspecified Cause] (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3012.jsonTenosynovitis [Unspecified Cause] (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3013.jsonPustular Skin Lesions (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.3014.jsonPustular Skin Lesions (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.302.jsonMeningococcal Disease (Tests for Neisseria meningitidis Nucleic Acid)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.303.jsonMeningococcal Disease (Tests for Neisseria meningitidis by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.368.jsonHIV Infection (Tests for HIV Antigen)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.380.jsonGiardiasis (Tests for Giardia species Antigen)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.426.jsonSTEC Infection (Tests for E. coli Shiga Toxin or Shiga Like Toxin)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.457.jsonAcute Hepatitis [Unspecified Cause] (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.466.jsonPlasmodium species (Tests by Microscopic Observation in Blood)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.570.jsonPlague (Tests for Yersinia pestis by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.588.jsonZika Virus Disease (Tests for Zika virus Nucleic Acid)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.589.jsonZika Virus Disease (Tests for Zika virus IgM Antibody)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.590.jsonZika Virus Disease (Disorders) (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.600.jsonTuberculosis (Tests for Mycobacterium tuberculosis Nucleic Acid)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.633.jsonChlamydia trachomatis Infection [Conjunctivitis] (Disorders) (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.688.jsonMyalgia (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.693.jsonInvasive Pneumococcal Disease (Tests for Streptococcus pneumoniae by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.726.jsonHIV Infection (Tests for HIV by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.731.jsonHIV Infection (Combination Tests for HIV Antigen and Antibody)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.771.jsonInvasive Pneumococcal Disease (Tests for Streptococcus pneumoniae in Specimen from Normally Sterile Site by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.772.jsonInvasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae in Specimen from Normally Sterile Site by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.783.jsonCongenital Rubella Syndrome (Disorders) (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.787.jsonMeningococcal Disease (Tests for Neisseria meningitidis in Specimen from Normally Sterile Site by Culture and Identification Method)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.838.jsonCaseating Granuloma (Finding by Microscopic Observation in Lab Results)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.859.jsonDizziness (SNOMED)active2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.861.jsonDizziness (ICD10CM)active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.901.jsonAcute Renal Failure [Unspecified Cause] (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.938.jsonGastrointestinal Hemorrhage [Unspecified Cause] (ICD10CM)active2025-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.939.jsonPulmonary Hemorrhage [Unspecified Cause] (SNOMED)active2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.960.jsonPlague (Tests for Yersinia pestis Antibody [Quantitative])active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.981.jsonBotulism (Tests for Clostridium botulinum Toxin)active2025-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.148.jsonInferior Vena Cava (IVC) Filter Placementactive2025-10ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.149.jsonInferior Vena Cava (IVC) Filter Placementactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.150.jsonInferior Vena Cava (IVC) Filter Placementactive2025-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.151.jsonInferior Vena Cava (IVC) Filter Placementactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.154.jsonCT Angiography of Chestactive2025-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.155.jsonCT Angiography of Chestactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.159.jsonAbdominal or Pelvic CT Scan with Contrastactive2025-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.167.jsonPulmonary Ventilation/Perfusion (VQ) Scanactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.169.jsonPulmonary Ventilation/Perfusion (VQ) Scanactive2025-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1147.170.jsonPulmonary Ventilation/Perfusion (VQ) Scanactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.274.jsonRacism Diagnoses ICD10CMactive2025-07ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.276.jsonRacism Diagnosesactive2025-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.277.jsonToxic Stress Goals SNOMED CTactive2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.279.jsonRacism Interventions SNOMED CTactive2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.286.jsonToxic Stress Diagnoses SNOMED CTactive2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.287.jsonToxic Stress Diagnoses ICD10CMactive2025-07ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.288.jsonToxic Stress Diagnosesactive2025-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.290.jsonToxic Stress Interventions SNOMED CTactive2025-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.308.jsonRacism Goals SNOMED CTactive2025-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.309.jsonProtective Factors Findings SNOMED CTactive2025-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.310.jsonProtective Factors Findings ICD10CMactive2025-07ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.311.jsonProtective Factors Findingsactive2025-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.312.jsonSocial Determinants of Health Programs SNOMED CTactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.266.jsonCT Angiography of Chestactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.408.jsonBladder Cancer Siteactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.409.jsonBladder Cancer Siteactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.410.jsonProstate Anatomical Siteactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.411.jsonProstate Anatomical Siteactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.412.jsonActive Depression Managementactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.413.jsonActive Depression Managementactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.415.jsonFollow Up for Above Normal BMIactive2025-10ushl7
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.416.jsonFollow Up For Below Normal BMIactive2025-10ushl7
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1251.11.jsonCongenital Heart Disease (structural)active2025-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.511.jsonCytotoxic Chemotherapiesactive2025-08ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.512.jsonBiphosphonate Therapy Not Done Medical Reason SNOMEDCTactive2025-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.513.jsonBiphosphonate Therapy Not Done Patient Reason SNOMEDactive2025-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.514.jsonNeoplasm of BrainICD9active2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.515.jsonNeoplasmofBrainICD9ICD10active2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1267.34.jsonPortable Medical Order Categoriesactive2025-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.16.jsonSolid Organ Transplant Proceduresactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.17.jsonSolid Organ Transplant Procedures SNOMEDactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.18.jsonSolid Organ Transplant Procedures ICD10PCSactive2025-10ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.20.jsonPruritus Diagnoses ICD10CMactive2025-10ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.21.jsonPruritusactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.22.jsonPruritus Diagnoses SNOMEDactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.23.jsonSolid Organ Transplant Diagnosis Codesactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.24.jsonNeuraxial Anesthesiaactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.25.jsonMethylprednisoloneactive2025-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.26.jsonIntravenous Heparin Administration Routeactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.27.jsonCVC Insertion Procedureactive2025-10ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.28.jsonVascular Surgeries ICD10PCSactive2025-10ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.29.jsonHeparin for VTE Treatmentactive2025-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.30.jsonNon Heparin Anticoagulants for VTE Treatmentactive2025-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1280.2.jsonExposure Locationactive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1290.19.jsonTranscranial doppler ultrasonography (TCD) HCPCSactive2025-09ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.267.jsonFamily History of Breast Canceractive2025-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.268.jsonFamily History of Breast Canceractive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.269.jsonPatient Declined Or Refused Genetic Testingactive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.270.jsonFamily History of Prostate Canceractive2025-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.271.jsonFamily History of Prostate Canceractive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.272.jsonBreast Cancer Maleactive2025-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.273.jsonPathological Stageactive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.274.jsonGenetic Counselingactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.275.jsonGenetic Counselingactive2025-10ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.276.jsonMetastatic Canceractive2025-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.283.jsonPaclitaxel Injectableactive2025-11ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.284.jsonEpidermal Growth Factor Receptor EGFR Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.285.jsonAnaplastic Lymphoma Kinase ALK Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.286.jsonROS1 Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.287.jsonNeurotrophic Receptor Tyrosine Kinase NTRK Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.288.jsonBRAF Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.289.jsonMET Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.290.jsonRET Gene Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.291.jsonKRAS Mutation Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.292.jsonPD L1 Testingactive2025-11ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.293.jsonRadiation Treatment Deliveryactive2025-11ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.250.jsonFamily History of Breast Canceractive2025-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.251.jsonFamily History of Prostate Canceractive2025-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.252.jsonBreast Cancer Maleactive2025-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.253.jsonSecondary Canceractive2025-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.254.jsonGenetic Counselingactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.258.jsonPlatinum Based Chemotherapy Agentactive2025-11ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1285.jsonUnilateral Mastectomyactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1286.jsonTotal Nephrectomyactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1287.jsonTotal Nephrectomyactive2025-10ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1288.jsonTotal Nephrectomyactive2025-10ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1289.jsonTotal Nephrectomyactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1290.jsonPartial Nephrectomyactive2025-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1291.jsonPartial Nephrectomyactive2025-10ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1292.jsonPartial Nephrectomyactive2025-10ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1293.jsonPartial Nephrectomyactive2025-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1348.jsonInfluenza Immunization Administeredactive2025-10ushl7cvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1926.jsonACE Inhibitor or ARB or ARNI Ingredientactive2023-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1927.jsonPsych Visit Psychotherapyactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.213.jsonProstate Cancer Treatmentactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.215.jsonProstate Specific Antigen Testactive2024-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.23.jsonHeart Failureactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.24.jsonHeart Failureactive2019-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.242.jsonPregnancyactive2024-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.243.jsonPregnancyactive2016-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.25.jsonHeart Failureactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.264.jsonAtrioventricular Blockactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.3000.jsonMetforminactive2019-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.303.jsonCardiac Paceractive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.305.jsonPatient Reason for ACE Inhibitor or ARB Declineactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.311.jsonPatient Reasonactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.313.jsonMedical Reasonactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.323.jsonSalvage Therapyactive2017-05ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.324.jsonSalvage Therapyactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.325.jsonPain Warranting Further Investigation for Prostate Canceractive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.39.jsonACE Inhibitor or ARB or ARNIactive2022-02ushl7rx
et.fhir.coreR4ValueSet-preferred-contact-method-vs.jsonPreferred Contact Method Value Setdraft2026-01uv
cezih.hr.cezih-osnovaR4ValueSet-g1sspol.jsonSpol (g1)draft2024-01uv
cezih.hr.cezih-osnovaR4ValueSet-hr-tip-posjete.jsonTip posjeteactive2024-01uv
cezih.hr.cezih-osnovaR4ValueSet-identifier-type.jsonENT Identifier Typesdraft2024-01uv
cezih.hr.cezih-osnovaR4ValueSet-observation-codes.jsonLOINC Codesdraft2024-01uvloinc
fhir.nwgenomics.nhs.ukR4ValueSet-admission-source.jsonAdmission Sourcedraft2026-02ushl7
hl7.terminologyR5ValueSet-v3-RoleCode.jsonv3 Code System RoleCodeactive0vocab2018-08uvhl7tho
hl7.terminologyR5ValueSet-v3-ActReason.jsonv3 Code System ActReasonactive1vocab2018-08uvhl7tho
hl7.terminologyR5ValueSet-v3-ActSite.jsonv3 Value Set ActSiteactive2018-08uvhl7tho
fhir.kenyaCoreIGR4ValueSet-location-type-vs.jsonLocation Type Value Setdraft2026-01ushl7internal
ndhm.inR4ValueSet-ndhm-program-code.jsonProgram Codedraft2022-09innationalinternal
ndhm.inR4ValueSet-ndhm-benefitcategory.jsonBenefit Categorydraft2022-07innationalsct
lt.hl7.fhir.vitalsignsR5ValueSet-waist-circumference-result-interpretation.jsonWaistCircumference Result Interpretation value setactive2025-12sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.140.jsonFerritinactive2024-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.12.1005.jsonRheumatoid Arthritisactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.11.1080.jsonRheumatoid Arthritisactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.11.1081.jsonRheumatoid Arthritisactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1428.jsonMyalgiaactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1439.jsonVomitingactive2024-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1525.jsonCognitive disorder Diagnosis ICD10active2024-06ushl7icd
hl7.terminologyR5ValueSet-v3-ChronicCareFacility.jsonChronicCareFacilityactive2014-03uvhl7tho
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113883.11.20.4.1.jsonDischargeSummaryDocumentTypeCodetrial-usecgp2025-07ushl7loinc
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113883.1.11.20.22.jsonHPDocumentTypetrial-usecgp2025-07ushl7loinc
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113762.1.4.1099.10.jsonCare Plan Document Typetrial-usecgp2025-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1139.jsonS4G Hyperlipidemiaactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1291.jsonS4G Cardiomyopathyactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1292.jsonS4G Tricuspid valve disorderactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1293.jsonS4G Pompe diseaseactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1294.jsonS4G Malignant hyperthermiaactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1295.jsonS4G Malignancyactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1297.jsonS4G Intestinal polypactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1298.jsonS4G Hamartomaactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1299.jsonS4G Diabetes mellitusactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1300.jsonS4G Muscular dystrophy and weaknessactive2022-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1325.jsonS4G Hamartoma and S4G Intestinal Polypactive2022-08ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1326.jsonS4G Malignancy and S4G Intestinal Polypactive2022-08ushl7vsac
hl7.terminologyR5ValueSet-v3-GeneralAcuteCareHospital.jsonGeneralAcuteCareHospitalactive2014-03uvhl7tho
hl7.terminologyR5ValueSet-v3-RehabilitationHospital.jsonRehabilitationHospitalactive2014-03uvhl7tho
hl7.terminologyR5ValueSet-v3-FontStyle.jsonFontStyleactive2014-03uvhl7tho
hl7.terminologyR5ValueSet-v3-TableRuleStyle.jsonTableRuleStyleactive2014-03uvhl7tho
hl7.terminologyR5ValueSet-v3-StyleType.jsonStyleTypeactive2014-03uvhl7tho
nictiz.fhir.nl.r4.zib2020R4ValueSet-GCS_MotorCodelijst-2.16.840.1.113883.2.4.3.11.60.40.2.12.8.2--20200901000000.jsonGCS_MotorCodelijstactivenlhl7tho oid
nictiz.fhir.nl.r4.zib2020R4ValueSet-GCS_MotorCodelijstKleuter-2.16.840.1.113883.2.4.3.11.60.40.2.12.8.7--20200901000000.jsonGCS_MotorCodelijstKleuteractivenlhl7tho oid